View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Keynotes & Leadership Announced for Global Clinical Trials 3rd Annual Event

  • July 3, 2012

  • New York – The Conference Forum has announced that the 3rd Annual Executing Global Clinical Trial’s event will take place on September 13-14 at the Fairmont Copley Square Hotel in Boston, MA.  “The trend to globalization creates opportunities and challenges for clinical trial management.  To be successful, we must focus on quality, ethics, fair market value, logistics and culture,” says Dr Barbara Skinn, Director of Collaborative Science Center of Excellence at Bristol-Myers Squibb.

    Led by Dr Skinn along with Dr Mitchell Katz, Executive Director Medical Research Operations at Purdue Pharma and Dr Aleksander Skuban, Director, Clinical R&D Emerging Markets at Merck, the conference addresses the most critical issues in globalizing complex studies to make significant progress to advance drug development for the benefit of patients globally.

    Dr Debra S. Barker, Chief Scientific Officer, Emerging Markets, Novartis and Dr Christopher Gallen,CEO, SK Bio-Pharmaceuticals are delivering the keynote addresses. David R. Jones, Expert Scientific Assessor (Pharmacotoxicologist), Licensing Division, Medicines and Healthcare Products Regulatory Agency (MHRA), UK is a featured presenter speaking on How to Do Clinical Trials in Europe: Clarifying Confusion, Changes & Updates.

    Regional Round Tables
    As part of the conference, attendees will participate in region-specific round table discussions, including one-on-one question time with an industry expert in the following countries:
    China ● EU ●  Latin America ●  India ●  Russia/Ukraine ●  Canada Brazil ●  Eastern Europe ●  Australia ●  Korea

    Participating companies include: Novartis; BBK Worldwide; CSL Behring; Endo; Strategic Clinical Research Consulting, LLC; Baxter Healthcare Corporation; SK Bio- Pharmaceuticals; Millenium Pharmaceuticals; Momenta Pharmaceuticals; Medicines and Healthcare Products Regulatory Agency (MHRA), UK; Purdue Pharma LP; EnVivo Pharmaceuticals, Inc; Target Health; AMAG Pharmaceuticals; Merck Brazil; Merck Research Laboratories; Bristol-Myers Squibb; AAHRPP; Marken and Zalicus.

    For more information on the complete speaking faculty and agenda details, click here.


    Early Bird ends 7/20. Combine with 10% off with code BLOG for best price. Register today, click here.